Adherence and identification of access barriers in patients with autoimmune diseases treated with an adalimumab biosimilar in Colombia. Universitas Scientiarum, [S. l.], p. S17, 2025. DOI: 10.11144/Javeriana.SCSI30.aaio. Disponível em: https://revistas.javeriana.edu.co/index.php/scientarium/article/view/41507. Acesso em: 1 nov. 2025.